9 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
EURopean Endeavour for Chimeric Antigen Receptor Therapies (EURE-CART)
Date du début: 1 janv. 2017, Date de fin: 31 déc. 2020,
Cancer is rapidly becoming the most frequent cause of death in EU. Though enormously expensive (several billions EUR/year), currently available anti-cancer therapies are major causes of chronic diseases. Adoptive immunotherapy with T cells genetically modified with a tumour-reactive chimeric antigen receptor (CAR) is an innovative therapeutic concept, promising to eradicate cancer without causing ...
Voir le projet
11
Participants partenaires
TERMINÉ
REgenerative Stem cell therapy for STroke in Europe (RESSTORE)
Date du début: 1 sept. 2015, Date de fin: 31 août 2020,
Stroke is the second leading cause of death in the world population. When not fatal, stroke often results in disability, due to motor and cognitive impairments, and secondary health problems affecting not only patients but also their families. Building on emerging preclinical and pilot clinical evidences, RESSTORE will focus on the clinical assessment of regenerative cell therapy to improve stroke ...
Voir le projet
29
Participants partenaires
TERMINÉ
Mobile Therapeutic Attention for Patients with Treatment Resistant Schizophrenia (m-RESIST)
Date du début: 1 janv. 2015, Date de fin: 31 déc. 2017,
In European Union approximately 5 million people suffer from psychotic disorders. Between 30-50% can be considered resistant to treatment, and 10-20% ultra-resistant. These patients present persistent positive symptomatology, require extensive periods of hospital care, and have a greater risk of excess mortality and multi-morbidity. In addition, a high proportion of the total cost for treating sch ...
Voir le projet
15
Participants partenaires
TERMINÉ
Molecular Analysis of Synaptic Dysfunctions Underlying Human Intellectual Disabilities (MASDUHID)
Date du début: 2 mai 2012, Date de fin: 1 mai 2016,
"Synapses of the central nervous system are the cellular structures mediating communication between neurons. Mouse mutations studies of synaptic proteins have shown how they ultimately modulate animal cognition and behavior. Furthermore, there is a growing body of data suggesting a central role of the synapse in neurodegenerative, mental and behavioral disorders. This project aims at understanding ...
Voir le projet
1
Participant partenaire
TERMINÉ
Developing and Evaluating Communication strategies to support Informed Decisions and practice based on Evidence (DECIDE)
Date du début: 1 janv. 2011, Date de fin: 31 déc. 2015,
Objective: To improve the dissemination of evidence-based recommendations by building on the work of the GRADE Working Group to develop and evaluate methods that address the targeted dissemination of guidelines.Background: Healthcare decision makers face challenges in understanding guidelines, including the quality of the evidence upon which recommendations are made, which often is not clear. Gui ...
Voir le projet
13
Participants partenaires
TERMINÉ
Vitamin D And LIfestyle Intervention for Gestational Diabetes Mellitus (GDM) Prevention (DALI)
Date du début: 1 mars 2010, Date de fin: 31 déc. 2015,
Europe is facing a rapidly growing threat from Type 2 diabetes mellitus (T2D), which is undoubtedly associated with an unhealthy diet and a more sedentary lifestyle. Evidence is accumulating that gestational diabetes mellitus (GDM) may be playing a role in this process. Thus it provides a significant opportunity for preventing future T2D. Not only is GDM prevalence on the rise, but intrauterine ex ...
Voir le projet
18
Participants partenaires
TERMINÉ
Overcome failure to Publish nEgative fiNdings (OPEN)
Date du début: 1 nov. 2011, Date de fin: 31 oct. 2013,
Full information about completed and ongoing clinical trials is the indispensable base for decision making about medical therapies and diagnostic procedures by patients and doctors. Equally, researchers and research organisations, ethics boards, governments and health system agencies, courts for social justice, pharmaceutical companies and all professional groups of the health care system are depe ...
Voir le projet
11
Participants partenaires
TERMINÉ
Regeneration of Cardiac Tissue Assisted by Bioactive Implants (RECATABI)
Date du début: 1 janv. 2010, Date de fin: 31 déc. 2012,
Heart failure is the end-stage of many cardiovascular diseases, but the leading cause is the presence of a large scar due acute to myocardial infarction. Current therapeutic treatments under development consist in cellular cardiomyoplasty where myocardial cells or stem cells are implanted alone or encapsulated in natural scaffolds (collagens) and grafted onto infarcted ventricles with the hope tha ...
Voir le projet
7
Participants partenaires
TERMINÉ
Evaluation of Integrated Cardiac Imaging for the Detection and Characterization of Ischemic Heart Disease (EVINCI-study)
Date du début: 1 janv. 2009, Date de fin: 30 juin 2012,
The main purpose of the EVINCI-study is to test the impact of combined “anatomo-functional” non invasive cardiac imaging for detection and characterization of Ischemic Heart Disease (IHD). The EVINCI-study is a prospective clinical European multicenter trial performed in a cohort of 700 patients with suspected IHD. Patients with intermediate pre-test probability will undergo clinical and biohumora ...
Voir le projet